Lumigan is a popular medication, containing Bimatoprost, used to treat Glaucoma and Ocular Hypertension.
Latisse, which also contains Bimatoprost, is used to enhance eyelash growth and make it longer and thicker.
Though Lumigan was originally developed to treat Glaucoma, it was found to affect eyelash growth as a side effect.
Latisse was, thus, developed as a brow-enhancement product.
This article will provide a detailed comparison between Lumigan vs Latisse to help you understand the difference.
The difference between Lumigan and Latisse
Latisse and Lumigan, both are used to enhance lash length and thickness.
Lumigan may also treat certain eye disorders, such as Glaucoma.Â
They both contain the same active ingredient, Bimatoprost, and are comparatively expensive compared to generic medicines.
The strength of Bimatoprost in Lumigan is 0.01%, whereas it is 0.03% in Latisse.
Individuals looking for cheaper and cost-effective versions of Bimatoprost can opt for Careprost.
Let us compare Lumigan with Latisse based on ingredients, packaging, and many other factors to help you make an informed decision.
Lumigan vs Latisse: Ingredients
Both Lumigan and Latisse contain Bimatoprost as the primary active ingredient.
As already mentioned, Lumigan contains 0.01% Bimatoprost and Latisse contains 0.03%.
According to a 2016 study, Bimatoprost can effectively treat eyelash and brow Hypotrichosis.
It is characterized by a lack of brow hair or loss of eyelash growth and thickness.
As a result, Lumigan and Latisse are equally efficient at making lashes longer and fuller.
Packaging of Lumigan and Latisse
Latisse comes with a specialized applicator that allows you to properly apply the medication along the eyelash.
Lumigan, on the other hand, does not come with a specialized applicator and is only accessible as an eyedrop.Â
This is due to the fact that Lumigan is primarily used to treat Glaucoma and Ocular Hypertension.
Lumigan vs Latisse: Cost
When deciding between Lumigan and Latisse, price is an important consideration.
Lumigan is typically covered by insurance when prescribed for Glaucoma, lowering individual costs.
Latisse, used for cosmetic purposes, is usually not covered by insurance and can be rather costly.
Uses of Lumigan and Latisse
Lumigan has been approved by the Food and Drugs Association (FDA) to treat Glaucoma and Ocular Hypertension.
Bimatoprost in Lumigan works by lowering excessive intraocular pressure (IOP).
Conversely, Latisse is the only medication approved by the FDA to treat brow Hypotrichosis.
It’s important to note that Lumigan can also help make your lashes longer and thicker.
A comparative analysis between Lumigan and Latisse
Both Lumigan and Latisse are used for the enhancement of eyelash growth.
With its active ingredient Bimatoprost, Lumigan is also prescribed to treat Glaucoma.
When considering whether to use Lumigan or Latisse, the choice largely depends on the individual’s needs.
Here’s a simplified comparison table between Lumigan and Latisse:
Aspect | Lumigan | Latisse |
Primary use | For treating Glaucoma | For enhancing eyelash growth |
Active ingredient | Bimatoprost | Bimatoprost |
Application | Applied in the eye | Applied to the lash line |
Eye health concerns | Lowered intraocular pressure, potential eye irritation | Potential eye irritation, pigmentation changes on the eyelid |
FDA approved | Yes | Yes |
This table clearly compares the primary differences and similarities between Lumigan and Latisse.
It highlights their distinct uses, application methods, and potential effects.
Always consult your doctor before medication to avoid potential risks and side effects.
Summing up
When considering Lumigan vs Latisse, evaluating your specific requirements, budget, and safety concerns is crucial.
Lumigan is a prescription medication for Glaucoma, and Latisse is known to make your eyelashes bigger.
Although both contain Bimatoprost as an active ingredient, there are variations in their uses, strength of Bimatoprost, and
packaging.
Generic Bimatoprost medications, such as Careprost, are recognized to treat these disorders effectively and are less expensive.
It is best to see an eye care specialist who can assist you in making an informed decision.
Frequently Asked Questions
Which is better: Lumigan or Latisse?
Latisse is specifically formulated for eyelash growth, while Lumigan, primarily a Glaucoma medication, may also enhance lashes.Â
However, Latisse is often preferred for cosmetic use due to its tailored application and efficacy.
Can I use Lumigan for eyelash growth?Â
Lumigan may lead to eyelash growth as a side effect. Still, it is primarily used to treat Glaucoma and Ocular Hypertension.
Before taking it for this purpose, you must consult your healthcare physician.
Is Lumigan the same as Latisse?Â
Lumigan and Latisse have the same active ingredient, Bimatoprost. Lumigan is developed for Glaucoma, while Latisse is for eyelash growth.Â
However, using Lumigan for lashes may have off-label benefits.
Are there any side effects associated with Lumigan and Latisse?
Lumigan and Latisse both have the potential to cause adverse effects such as eye redness, itching, and darkening of the eyelid skin.Â
If you notice any strange symptoms, contact your healthcare professional.
When referencing outside resources, GoodrxMedicine always provides full citations. To learn more about the measures we use to maintain the quality of our content, please review our Content Information Policy.